13,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
payback
7 °P sammeln
  • Gebundenes Buch

A government monopoly over drug regulation is not sacrosanct. This hard-hitting book describes the current regulation of drugs by the FDA and proposes a model for fundamental, yet workable, reform--including an innovative proposal for drug testing and certification review.

Produktbeschreibung
A government monopoly over drug regulation is not sacrosanct. This hard-hitting book describes the current regulation of drugs by the FDA and proposes a model for fundamental, yet workable, reform--including an innovative proposal for drug testing and certification review.
Autorenporträt
Henry I. Miller, M.S., M.D., is a research fellow at the Hoover Institution. His research focuses on public policy toward science and technology, especially pharmaceutical development and the new biotechnology. His work often emphasizes the excessive costs of government regulation and models for regulatory reform.